Treating patients with type 2 diabetes who cannot control blood sugar levels by diet and exercise alone.
Glimepiride 2mg
$1.08
Avandia
Controlling blood sugar levels, along with diet and exercise, in patients with type 2 diabetes.
Rosiglitazone 2/4/8mg
$0.52
Capoten
Treating high blood pressure, heart failure, or certain diabetic kidney problems.
Captopril 25mg
$0.61
Glucophage
Treating type 2 diabetes.
Metformin 500/850mg
$0.36
Glucotrol
Glipizide sr 5/10mg
$0.40
Prandin
Managing type 2 (non-insulin-dependent) diabetes.
Repaglinide 0.5/1/2mg
$0.52
I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
I will be in touch.
Thanks.
USP Chief Science Officer Darrell Abernethy To Receive ACCP Distinguished Service Award
The U.S. Pharmacopeial (USP) Convention is pleased to announce that its chief science officer, Darrell Abernethy, M.D., Ph.D., will be honored with the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award at the 2008 ACCP Annual Meeting in Philadelphia, Pa., September 14-16. Dr. Abernethy is being recognized for his lasting contributions to cardiovascular clinical pharmacology. As chief science officer of USP, Dr.
By 2012, Legitimate Generics Will Account For 20% Of Brazil's Pharmaceuticals And Healthcare Market
Research and Markets has announced the addition of the "Brazil Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The "Brazil Pharmaceuticals and Healthcare Report" provides independent forecasts and competitive intelligence on Brazils pharmaceuticals and healthcare industry. Brazil's pharmaceutical market remains one of the bright spots globally, having posted 17.0% growth in 2007 and reaching an estimated value of US$12.9bn in final consumer prices.
Patent System For Drugs 'Morally Unacceptable'
Major drugs companies are using fierce lobbying tactics to protect a pharmaceutical patent system that is "simply morally unacceptable", a world-leading political philosopher told a major meeting of UK and European pharmacologists.
European Biotech Industry Identifies The Real Culprits Causing Food Price Rises
The European Biotech Industry Association (EuropaBio) questions the premises and the methods used by recent reports, including the recently leaked and unofficial World Bank internal note which claims that 75% of the recent price increase of food is due to increasing demand for biofuel.
